Kaposi's sarcoma is the most common cancer in persons with the acquired immunodeficiency syndrome (AIDS) worldwide, and is the most prevalent cancer in all persons living in Zimbabwe. The occurrence of KS in persons with, and without AIDS has been linked to infection with the recently discovered human herpesvirus 8 (HHV-8; also called Kaposi's sarcoma-associated virus or KSHV). Available data strongly suggest that HHV-8 is the causative agent of Kaposi's sarcoma and that coinfection with human immunodeficiency virus type 1 (HIV-1) and HHV8 greatly increases the risk of developing Kaposi's sarcoma. Thus, the present epidemic of Kaposi's sarcoma in Zimbabwe is likely the result of a high risk of concomitant infection with both HHV8 and HIV-1 in Zimbabweans. To date, the prevalence of HHV8 in Zimbabweans has not been defined and the relationship between HHV8 replication, HIV-1 related immunodeficiency and Kaposi's sarcoma pathogenesis is unknown. Even though Kaposi's sarcoma is epidemic in Zimbabwe, Zimbabwean investigators have limited experience with the techniques used to diagnose and monitor HHV8 infection and detailed studies on HHV8 epidemiology and pathogenesis in Zimbabwe have not been conducted. The purpose of the present proposal is to develop a strong collaboration between American and Zimbabwean investigators for studies on HHV8 infection and Kaposi's sarcoma. These studies will define the prevalence of HHV8 infection in Zimbabwe and to determine the relationship between HHV8 gene expression and Kaposi's sarcoma disease status in Zimbabweans with Kaposi's sarcoma. In addition to providing important information on the epidemiology and pathogenesis of HHV8 infection, it is expected that these initial studies will provide the basis for future investigations on the role of HHV8 in Kaposi's sarcoma.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
Small Research Grants (R03)
Project #
5R03TW001123-02
Application #
6188769
Study Section
Special Emphasis Panel (ZRG1-AARR-6 (01))
Program Officer
Mcdermott, Jeanne
Project Start
1999-09-30
Project End
2002-08-31
Budget Start
2000-09-30
Budget End
2001-08-31
Support Year
2
Fiscal Year
2000
Total Cost
$40,320
Indirect Cost
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Campbell, Thomas B; Borok, Margaret; Ndemera, Buxton et al. (2009) Lack of evidence for frequent heterosexual transmission of human herpesvirus 8 in Zimbabwe. Clin Infect Dis 48:1601-8
White, Tiffany; Hagen, Moira; Gudza, Ivy et al. (2008) Genetic diversity of the Kaposi's sarcoma herpesvirus K1 protein in AIDS-KS in Zimbabwe. J Clin Virol 42:165-71